$TRVI
Trevi Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is TRVI down today? It is at $18.43 (-1.18%), and our scanner flagged it 53 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment TRVI spikes, and full due diligence on TRVI — key stats, earnings, dilution and insider activity. Free.
Get free $TRVI alerts the moment volume spikes
Our scanner flagged $TRVI 53 times in the last 30 days. Create a free account to track $TRVI, build a watchlist, and get instant unusual-volume alerts — plus 5 free premium days, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $18.43
- Change today
- -1.18%
- Previous close
- $18.65
- 52-week range
- $6.55 – $20.22
- Market cap
- $2.65B
- Institutional own.
- 99.9%
- Total held
- 100.0%
- Short interest
- 12.7M ▼ -9% vs prior · as of 2026-07-15
- Days to cover
- 4.8d
- Avg daily volume
- 1.9M
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Exchange
- XNAS
- 5m
- 0.3x
- 15m
- 0.7x
- 1h
- 2.7x
- 1D
- 0.2x
Get free TRVI + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $TRVI down today?
Here is the latest on TRVI from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for TRVI today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystCharter / Bylaw Change · Shareholder Vote, from the latest SEC filing. Read it →Analyst data via Nasdaq. Not investment advice.
Insiders
0 buys, 0 sells last 3 months (0/0 over 12 months)Show 12 recent transactionsMinimize 12 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Galletta Christopher Officer | Other | 4K | added 19% | 26K | $2K at $0.510 | Dec 2, 25 |
Sciascia Thomas Officer | Sold (automatic/other) | -3K | sold 1.2% | 221K | $17K at $6.60 | Mar 25, 25 |
Sciascia Thomas Officer | Other | 3K | added 1.2% | 224K | $4K at $1.43 | Mar 25, 25 |
Good Jennifer L Officer | Sold (automatic/other) | -5K | sold 2.4% | 213K | $35K at $6.58 | Mar 21, 25 |
Good Jennifer L Officer | Other | 5K | added 2.5% | 219K | $8K at $1.43 | Mar 21, 25 |
Simon Farrell Officer | Sold (automatic/other) | -81K 0.06% of company | sold 51% | 77K | $547K at $6.73 | Mar 10, 25 |
Simon Farrell Officer | Other | 113K 0.08% of company | added 100% | 158K | $57K at $0.510 | Mar 10, 25 |
Delfini Lisa Officer | Other | 5K | added 8.4% | 65K | $3K at $0.510 | Jan 8, 25 |
Delfini Lisa Officer | Other | 1K | added 1.7% | 60K | $510 at $0.510 | Jan 7, 25 |
Galletta Christopher Officer | Other | 15K 0.01% of company | added 100% | 20K | $8K at $0.510 | Dec 13, 24 |
Good Jennifer L Officer | Sold (automatic/other) | -2K | sold 0.9% | 213K | $6K at $3.04 | Sep 9, 24 |
Good Jennifer L Officer | Other | 2K | added 0.9% | 215K | $3K at $1.43 | Sep 9, 24 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Dilution watch
Recent offeringAt-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing). If $TRVI runs, these filings show who may be positioned to sell new or newly-registered shares into the move.
- At-the-market (ATM) program — sells new shares into the market gradually over time · Priced at $13.00/share
Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.
$TRVI Sentiment
BullishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$TRVI Activity
News, unusual-volume alerts, AI-trader trades and community chatter — the whole story, newest first.
Stocks similar to TRVI
Comparable names in pharmaceutical preparations, closest in size first.
TRVI stock FAQ
Why is $TRVI down today?
Here is the latest on TRVI from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for TRVI today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
What is the TRVI stock price today?
TRVI last traded at $18.43, down 1.18% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Where can I see live TRVI alerts?
The TRVI Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged TRVI 53 times in the last 30 days.
What exchange is TRVI on?
TRVI (Trevi Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $2.65B in the PHARMACEUTICAL PREPARATIONS sector.
Is TRVI good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge TRVI for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.